House dust mite sensitization in toddlers predicts current wheeze at age 12 years

Caroline J Lodge1, Adrian J Lowe, Lyle C Gurrin

  • 1Centre for MEGA Epidemiology, University of Melbourne, Melbourne, Australia. clodge@unimelb.edu.au

Insights

Early house dust mite (HDM) sensitization in children with allergy risk factors predicts future asthma. Identifying HDM sensitization in infants with wheeze or eczema can identify high-risk children for asthma.

Area of Science:

  • Pediatric Allergy and Immunology
  • Respiratory Medicine
  • Epidemiology

Background:

  • Identifying children at risk for asthma is crucial for early intervention.
  • Allergen sensitization is a potential early marker for identifying high-risk children.

Purpose of the Study:

  • To investigate if skin prick tests (SPTs) for allergens in early childhood predict wheeze at age 12.
  • To assess the predictive value of sensitization to specific allergens, particularly house dust mite (HDM), for later asthma development.

Main Methods:

  • A birth cohort of 620 children, oversampled for familial allergy, underwent SPTs at 6, 12, and 24 months.
  • Sensitization status (monosensitized, polysensitized) to 6 allergens was recorded.
  • Wheeze and eczema were monitored during the first two years, and wheeze was assessed again at age 12.

Main Results:

  • Positive SPT to house dust mite (HDM) at ages 1 or 2 years significantly predicted wheeze at age 12.
  • HDM sensitization in 1-year-olds with wheeze or eczema substantially increased the probability of wheeze at age 12.
  • The predictive value was observed even in children with both eczema and wheeze at age 1.

Conclusions:

  • HDM sensitization in early childhood (ages 1-2) is a significant predictor of asthma in children with a family history of allergy.
  • These findings suggest that early allergen sensitization assessment, particularly for HDM, can inform management strategies for high-risk children.
  • Targeted interventions for sensitized infants may help mitigate asthma development.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Allergic Reactions02:06

Allergic Reactions

Overview
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...